Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1

University of Pennsylvania

Status and phase: Completed; Phase 3

Conditions: Opioid-Related Disorders

Treatments: Drug: Buprenorphine/naloxone

Study type: Interventional

Funder types: Other

Identifiers

NCT00078130

NIDA-CTN-0010-1

Details and patient eligibility

About

The purpose of this study is to compare two 3-month treatments for adolescents/young adults who are addicted to heroin: buprenorphine/naloxone combined with psychosocial therapy and treatment as usual, a 7-14 day detoxification with buprenorphine and three weeks of psychosocial therapy.

Sex: All

Ages: 14 to 21 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Male and non-pregnant female subjects seeking outpatient treatment for opioid dependence with physiological features without serious medical or psychiatric disorders.